CIM
PBYI icon

CenturyLink Investment Management’s Puma Biotechnology PBYI Stock Holding History

CenturyLink Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,761
Closed -$322K – 284
2015
Q2 		$322K Buy
2,761
+320
+13% +$58K 0.11% 206
2015
Q1 		$576K Sell
2,441
-850
-26% -$182K 0.19% 165
2014
Q4 		$623K Buy
3,291
+1,472
+81% +$327K 0.18% 164
2014
Q3 		$434K Sell
1,819
-1,800
-50% -$370K 0.15% 179
2014
Q2 		$239K Buy
3,619
+1,695
+88% +$121K 0.07% 216
2014
Q1 		$200K Buy
+1,924
New +$226K 0.06% 220

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CenturyLink Investment Management's PBYI Position: Q3 2015 in Review

CenturyLink Investment Management sold out of Puma Biotechnology (PBYI) in Q3 2015, closing a stake of 2,761 shares — an estimated $322K sold.

CenturyLink Investment Management first reported a position in PBYI in Q1 2014 and held it in 6 quarters. The position peaked at $623K in Q4 2014. 163 funds tracked by Wall St. Rank hold PBYI as of Q3 2015.

  • CenturyLink Investment Management reported no remaining Puma Biotechnology position as of Q3 2015 after selling out during the quarter.
  • CenturyLink Investment Management sold 2,761 Puma Biotechnology shares in Q3 2015, an estimated $322K.
  • CenturyLink Investment Management first reported a position in Puma Biotechnology in Q1 2014 and held it in 6 quarters.
  • CenturyLink Investment Management's Puma Biotechnology position peaked at $623K in Q4 2014.
  • 163 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2015.

Based on CenturyLink Investment Management's 13F filing for Q3 2015, filed 20 Oct 2015.